BridgeBio Pharma (BBIO) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 94.9%
EBITDA Margin: -53.9%
Op. Margin: -54.5%
Net Margin: -85.6%

Op. margin of -54.5% is up 35.0% YoY — cost efficiency is improving. Net margin at -85.6% and gross margin of 94.9% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit